- Home
- ONCY vs RCON Comparison
ONCY vs RCON Comparison
Compare ONCY & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- RCON
- Stock Information
- Founded
- ONCY 1998
- RCON 2007
- Country
- ONCY Canada
- RCON China
- Employees
- ONCY N/A
- RCON N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- RCON Oilfield Services/Equipment
- Sector
- ONCY Health Care
- RCON Energy
- Exchange
- ONCY Nasdaq
- RCON Nasdaq
- Market Cap
- ONCY 89.7M
- RCON 86.1M
- IPO Year
- ONCY 1999
- RCON 2009
- Fundamental
- Price
- ONCY $1.20
- RCON $1.92
- Analyst Decision
- ONCY Strong Buy
- RCON
- Analyst Count
- ONCY 5
- RCON 0
- Target Price
- ONCY $5.00
- RCON N/A
- AVG Volume (30 Days)
- ONCY 1.0M
- RCON 25.1K
- Earning Date
- ONCY 11-11-2025
- RCON 09-26-2025
- Dividend Yield
- ONCY N/A
- RCON N/A
- EPS Growth
- ONCY N/A
- RCON N/A
- EPS
- ONCY N/A
- RCON N/A
- Revenue
- ONCY N/A
- RCON $8,996,572.00
- Revenue This Year
- ONCY N/A
- RCON N/A
- Revenue Next Year
- ONCY N/A
- RCON $12.17
- P/E Ratio
- ONCY N/A
- RCON N/A
- Revenue Growth
- ONCY N/A
- RCON N/A
- 52 Week Low
- ONCY $0.33
- RCON $1.40
- 52 Week High
- ONCY $1.51
- RCON $7.16
- Technical
- Relative Strength Index (RSI)
- ONCY 44.08
- RCON 39.87
- Support Level
- ONCY $1.20
- RCON $1.90
- Resistance Level
- ONCY $1.47
- RCON $2.07
- Average True Range (ATR)
- ONCY 0.08
- RCON 0.11
- MACD
- ONCY -0.02
- RCON 0.01
- Stochastic Oscillator
- ONCY 3.23
- RCON 11.89
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.